Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI7352 in painful osteoarthritis of the knee
NCT04675034Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2020
- Primary completion
- Aug 2023
- Modality
- Bispecific Antibodies
- Countries
- 6
01
Overview
A Phase 2 trial of MEDI7352 in knee osteoarthritis (OA), sponsored by AstraZeneca. Started Dec 2020; status: completed.
02
Drugs
MEDI7352
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04675034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04675034.